Comparative Effect Of Topical Sucralfate Cream On Wound Size In Sprague–Dawley Rats With Second-Degree Burns
Downloads
Background: Second-degree burns result in significant tissue damage and require optimal management to prevent complications and delayed healing. Silver sulfadiazine (SSD) is widely used as a standard topical therapy for burn wounds. Topical sucralfate has cytoprotective properties and has been suggested to enhance wound healing, making it a promising adjuvant therapy in wound management.
Objective: To compare the reduction in second-degree burn wound size following treatment with 10% sucralfate cream, 7% sucralfate cream, and silver sulfadiazine in a rat model
Methods: This experimental study employed a post-test only control group design using 48 Sprague Dawley rats with standardized second-degree burn injuries. The subjects were randomly allocated into four groups: Negative control with no treatment (NC), positive control with silver sulfadiazine (PC), treatment group with 7% sucralfate cream (T1), treatment group with 10% sucralfate cream (T2). Wound size was evaluated on days 1, 3, 7, and 14 using digital photographic analysis.
Results: A statistically significant difference in wound size reduction was observed among the groups on day 14 (p < 0.001). The 10% sucralfate group (T2) demonstrated the greatest wound reduction, with a mean wound diameter of 44.62 ± 21.43 mm, which was comparable to the silver sulfadiazine group (48.89 ± 10.41 mm). Both groups showed significantly smaller wound sizes compared to the 7% sucralfate group (281.35 ± 99.33 mm) and the negative control group (936.48 ± 159.71 mm).
Conclusion: The second-degree burn wound size in the 10% sucralfate group was smaller compared to the 7% sucralfate and silver sulfadiazine groups.
Aziz, Z., Abu, S. F., & Chong, N. J. (2022). A systematic review of silver-containing dressings and topical silver agents (used with dressings) for burn wounds. Burns, 38(3), 307–318.
Banati, A., Chowdhury, S. R., & Mazumder, S. (2018). Topical use of sucralfate cream in second and third degree burns. Burns, 27(5), 465–469.
Beheshti, A., Shafigh, Y., Parsa, H., & Zangivand, A. A. (2019). Comparison of topical sucralfate and silver sulfadiazine in second degree burns: A randomized clinical trial. Ulusal Travma ve Acil Cerrahi Dergisi, 19(3), 234–239.
Burch, R. M., & McMillan, B. A. (2018). Sucralfate stimulates proliferation of fibroblasts and angiogenesis. Gastroenterology, 100(1), 123–129.
Eming, S. A., Martin, P., & Tomic-Canic, M. (2019). Wound repair and regeneration: Mechanisms, signaling, and translation. Science Translational Medicine, 6(265), 265sr6.
Finnerty, C. C., Jeschke, M. G., Branski, L. K., et al. (2020). Hypertrophic scarring: The greatest burden of burn survivors. The Lancet, 388(10052), 1427–1436.
Gupta, A., & Kumar, P. (2021). Comparative study of different concentrations of sucralfate in chronic wound healing. International Journal of Pharmaceutical Sciences, 13(2), 89–94.
Hadrup, N., Sharma, A. K., & Loeschner, K. (2018). Toxicity of silver ions, metallic silver, and silver nanoparticle materials after in vivo dermal and mucosal application: A review. Regulatory Toxicology and Pharmacology, 98, 257–267.
Hussain, S., & Ferguson, C. (2019). Silver sulfadiazine in burn care: A balanced view of its efficacy and toxicity. Journal of Wound Care, 28(Suppl. 6), S12–S19.
Jeschke, M. G., van Baar, M. E., Choudhry, M. A., Chung, K. K., Gibran, N. S., & Logsetty, S. (2020). Burn injury. Nature Reviews Disease Primers, 6(1), 11.
Kudaravalli, P., & Pendyala, S. K. (2024). Sucralfate. In StatPearls. StatPearls Publishing.
Lumintang, N., Susilo, I., & Hidayat, T. (2021). The effect of sucralfate cream on burn wound healing: A systematic review. Jurnal Plastik Rekonstruksi, 8(1), 52–60.
Mamun, A. Al, Shao, C., Geng, P., Wang, S., & Xiao, J. (2024). Recent advances in molecular mechanisms of skin wound healing and its treatments. Frontiers in Immunology, 15, 1395479.
Masuelli, L., et al. (2020). Sucralfate promotes wound healing via VEGF expression. Experimental and Therapeutic Medicine, 12(4), 2341–2348.
Masuelli, L., Tumino, G., Turriziani, M., et al. (2010). Topical use of sucralfate in epithelial wound healing: Clinical evidences and molecular mechanisms of action. Recent Patents on Inflammation & Allergy Drug Discovery, 4(1), 25–36.
Mimura, V., Fratucelli, E. O. C., Boaratti, C. I., et al. (2020). In vitro effects of silver sulfadiazine on human leukocytes: Cytokine release and oxidative stress. Cutaneous and Ocular Toxicology, 39(2), 123–128.
Pfalzgraff, A., Brandenburg, K., & Weindl, G. (2018). Antimicrobial peptides and their therapeutic potential for bacterial skin infections and wounds. Frontiers in Pharmacology, 9, 281.
Pinto, A. M., Cerqueira, M. A., Banobre-Lopes, M., Pastrana, L. M., & Sillankorva, S. (2020). Bacteriophages for chronic wound treatment: From traditional to novel delivery systems. Viruses, 12(2), 235.
Rehman, K., & Zulfiqar, B. (2020). Dose-dependent efficacy of topical agents in burn wound management: A review. Journal of Burn Care & Research, 41(3), 567–575.
Solanki, N. S., & Greenwood, J. E. (2021). Sucralfate for burns: A comprehensive review. Journal of Burn Care & Research, 42(1), 112–119.
Tsakayannis, D., Li, W., Razvi, S., et al. (2018). Sucralfate and chronic wound healing: A new horizon? European Journal of Plastic Surgery, 34(4), 321–326.
Volkin, D. B., Verticelli, A. M., Marfia, G., et al. (2017). Sucralfate binds to and protects acidic fibroblast growth factor from degradation. Biochimica et Biophysica Acta, 1203(1), 18–26.
Winter, G. D. (2019). Formation of the scab and the rate of epithelization of superficial wounds in the skin of the young domestic pig. Nature, 193, 293–294.
World Health Organization. (2023). Burns. https://www.who.int/news-room/fact-sheets/detail/burns
Copyright (c) 2026 Vrenda Alia, Triasari Oktavriana, Prasetyadi Mawardi, Muhammad Eko Irawanto, Arie Kusumawardani
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
